Breaking news

FDA Clears First Topical Form of Minocycline for Acne, i.e. 4% minocycline topical foam (Amzeeq, Foamix Pharmaceuticals) to treat inflammatory lesions of nonnodular moderate to severe acne vulgaris in adults and in children aged 9 years or older.